Literature DB >> 18983539

Gpnmb is a melanoblast-expressed, MITF-dependent gene.

Stacie K Loftus1, Anthony Antonellis, Ivana Matera, Gabriel Renaud, Laura L Baxter, Duncan Reid, Tyra G Wolfsberg, Yidong Chen, Chenwei Wang, Megana K Prasad, Seneca L Bessling, Andrew S McCallion, Eric D Green, Dorothy C Bennett, William J Pavan.   

Abstract

Expression profile analysis clusters Gpnmb with known pigment genes, Tyrp1, Dct, and Si. During development, Gpnmb is expressed in a pattern similar to Mitf, Dct and Si with expression vastly reduced in Mitf mutant animals. Unlike Dct and Si, Gpnmb remains expressed in a discrete population of caudal melanoblasts in Sox10-deficient embryos. To understand the transcriptional regulation of Gpnmb we performed a whole genome annotation of 2,460,048 consensus MITF binding sites, and cross-referenced this with evolutionarily conserved genomic sequences at the GPNMB locus. One conserved element, GPNMB-MCS3, contained two MITF consensus sites, significantly increased luciferase activity in melanocytes and was sufficient to drive expression in melanoblasts in vivo. Deletion of the 5'-most MITF consensus site dramatically reduced enhancer activity indicating a significant role for this site in Gpnmb transcriptional regulation. Future analysis of the Gpnmb locus will provide insight into the transcriptional regulation of melanocytes, and Gpnmb expression can be used as a marker for analyzing melanocyte development and disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983539      PMCID: PMC2714741          DOI: 10.1111/j.1755-148X.2008.00518.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  46 in total

1.  Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.

Authors:  S B Potterf; M Furumura; K J Dunn; H Arnheiter; W J Pavan
Journal:  Hum Genet       Date:  2000-07       Impact factor: 4.132

2.  Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.

Authors:  C Verastegui; K Bille; J P Ortonne; R Ballotti
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 3.  The genetic regulation of pigment cell development.

Authors:  Debra L Silver; Ling Hou; William J Pavan
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish.

Authors:  Shannon Fisher; Elizabeth A Grice; Ryan M Vinton; Seneca L Bessling; Akihiro Urasaki; Koichi Kawakami; Andrew S McCallion
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.

Authors:  Samir M Abdelmagid; Mary F Barbe; Israel Arango-Hisijara; Thomas A Owen; Steven N Popoff; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2007-01       Impact factor: 6.384

6.  Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

Authors:  An Chi; Julio C Valencia; Zhang-Zhi Hu; Hidenori Watabe; Hiroshi Yamaguchi; Nancy J Mangini; Hongzhan Huang; Victor A Canfield; Keith C Cheng; Feng Yang; Riichiro Abe; Shoichi Yamagishi; Jeffrey Shabanowitz; Vincent J Hearing; Cathy Wu; Ettore Appella; Donald F Hunt
Journal:  J Proteome Res       Date:  2006-11       Impact factor: 4.466

7.  The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes.

Authors:  Fabien Murisier; Sabrina Guichard; Friedrich Beermann
Journal:  Pigment Cell Res       Date:  2007-06

8.  Novel MITF targets identified using a two-step DNA microarray strategy.

Authors:  Keith S Hoek; Natalie C Schlegel; Ossia M Eichhoff; Daniel S Widmer; Christian Praetorius; Steingrimur O Einarsson; Sigridur Valgeirsdottir; Kristin Bergsteinsdottir; Alexander Schepsky; Reinhard Dummer; Eirikur Steingrimsson
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

9.  Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes.

Authors:  Christina Wasmeier; Maryse Romao; Lynn Plowright; Dorothy C Bennett; Graça Raposo; Miguel C Seabra
Journal:  J Cell Biol       Date:  2006-10-16       Impact factor: 10.539

10.  Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1.

Authors:  Gareth R Howell; Richard T Libby; Jeffrey K Marchant; Lawriston A Wilson; Ioan M Cosma; Richard S Smith; Michael G Anderson; Simon W M John
Journal:  BMC Genet       Date:  2007-07-03       Impact factor: 2.797

View more
  28 in total

1.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  Genetic dissection of the Gpnmb network in the eye.

Authors:  Hong Lu; Xusheng Wang; Matthew Pullen; Huaijin Guan; Hui Chen; Shwetapadma Sahu; Bing Zhang; Hao Chen; Robert W Williams; Eldon E Geisert; Lu Lu; Monica M Jablonski
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-13       Impact factor: 4.799

3.  The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.

Authors:  Alexander C Theos; Brenda Watt; Dawn C Harper; Karolina J Janczura; Sarah C Theos; Kathryn E Herman; Michael S Marks
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-02       Impact factor: 4.693

Review 4.  Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Authors:  Hen Prizant; Stephen R Hammes
Journal:  Endocrinology       Date:  2016-07-13       Impact factor: 4.736

Review 5.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

6.  Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma.

Authors:  Sarah E Henson; Travis Morford; Mary-Pat Stein; Randolph Wall; Cindy S Malone
Journal:  Acta Histochem       Date:  2010-12-09       Impact factor: 2.479

7.  mitfa is required at multiple stages of melanocyte differentiation but not to establish the melanocyte stem cell.

Authors:  Stephen L Johnson; Anhthu N Nguyen; James A Lister
Journal:  Dev Biol       Date:  2010-12-10       Impact factor: 3.582

8.  Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.

Authors:  Toshihiko Hoashi; Shinichi Sato; Yuji Yamaguchi; Thierry Passeron; Kunihiko Tamaki; Vincent J Hearing
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

Review 9.  Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.

Authors:  Kevin M Budge; Matthew L Neal; Jason R Richardson; Fayez F Safadi
Journal:  Mol Neurobiol       Date:  2017-08-30       Impact factor: 5.590

10.  Comparison of melanoblast expression patterns identifies distinct classes of genes.

Authors:  Stacie K Loftus; Laura L Baxter; Kristina Buac; Dawn E Watkins-Chow; Denise M Larson; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-26       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.